Clinically impactful KIF1A research means collaboration and urgency. We have a robust pre-clinical program collecting extensive longitudinal data and testing pre-clinical therapeutics on animal models and cell lines. All of our information is freely accessible to the scientific community, so connect today and ask us questions about our kids. We can give you a clear clinical picture of what the disease is and what a meaningful clinical change would be from a new therapeutic.
Our KIF1A researchers are superheroes. They include the Chung Lab at Columbia University Medical Center, The Jackson Laboratory, Vallee Lab, Berger Lab and more. If your research includes kinesins, motor proteins, neurodegeneration, epilepsy or gene therapy, we want to hear from you.